Cesarone MR, Belcaro G., Pellegrini L., et al. Circulating endothelial cells in venous blood as a marker of endothelial damage in chronic venous insufficiency: improvement with Venoruton . J Cardiovasc Pharmacol Ther. 2006;11(1):93-98.
2.
Cesarone MR, Belcaro G., Pellegrini L., et al. Venoruton vs Daflon: evaluation of effects on quality of life in chronic venous insufficiency. Angiology. 2006;57(2):131-138.
3.
Cesarone MR, Belcaro G., Ricci A., et al. Prevention of edema and flight microangiopathy with Venoruton (HR), (O-[β-hydroxyethyl]-rutosides) in patients with varicose veins. Angiology. 2005;56(3):289-293.
4.
Cesarone MR, Belcaro G., Pellegrini L., et al. HR, O-(βhydroxyethyl)-rutosides; (Venoruton): rapid relief of signs/symptoms in chronic venous insufficiency and microangiopathy: a prospective, controlled study. Angiology. 2005;56(2):165-172.
5.
Belcaro G.Once We Were Hunters. London, England: Imperial College Press; 2002
6.
Kulisić T., Krisko A., Dragović-Uzelac V., Milos M., Pifat G.The effects of essential oils and aqueous tea infusions of oregano (Origanum vulgare L. spp. hirtum), thyme (Thymus vulgaris L.) and wild thyme (Thymus serpyllum L.) on the copper-induced oxidation of human low-density lipoproteinsInt J Food Sci Nutr. 2007;58(2):87-93.
7.
Hsu IP, Jou HJ, Huang CW, Wang TA, Wu WHThe effects of soygerm extracts on blood lipoproteins, antioxidative capacity and urinary estrogen metabolites in postmenopausal women on hormone therapy . Int J Gynaecol Obstet. 2007;98(1):29-33.
8.
Botelho FV, Alvarez-Leite JI, Lemos VS, et al. Physicochemical study of floranol, its copper(II) and iron(III) complexes, and their inhibitory effect on LDL oxidation. J Inorg Biochem. 2007;101(6):935-943.
9.
Milde J., Elstner EF, Grassmann J.Synergistic effects of phenolics and carotenoids on human low-density lipoprotein oxidation. Mol Nutr Food Res. 2007;51(8): 956-961.
10.
Cesarone MR , Incandela L., DeSanctis MT, Belcaro G., Dugall M., Acerbi G.Variations in plasma free radicals in patients with venous hypertension with HR (Paroven, Venoruton; O-[β-hydroxyethyl]-rutosides): a clinical, prospective, placebo-controlled, randomized trial. J Cardiovasc Pharmacol Ther.2002;7(suppl 1): S25-S28.
11.
Maurya DK, Balakrishnan S., Salvi VP, Nair CKProtection of cellular DNA from γ-radiation-induced damages and enhancement in DNA repair by troxerutin. Mol Cell Biochem. 2005;280(1-2):57-68.
